News

By Matheus Dias Montecasciano

April 15, 2021

ANVISA opens a Public Consultation to improve the reliance on foreign regulatory authorities’ opinions

ANVISA’s Board of Directors opened a Public Consultation (“PC 1,039/2021”), available to contributions between 04/15/2021 and 06/15/2021, to discuss a proposed regulation ANVISA opens a Public Consultation to improve the reliance on foreign regulatory authorities’ opinions

Ler notícia

October 23, 2020

Pharma & Medical Device Regulation in Brazil

Our partner and Head of Regulatory Anderson Ribeiro, together with his associates Lucas Calabria and Matheus Montecasciano, co-sign the chapter “Pharma & Pharma & Medical Device Regulation in Brazil

Ler notícia